IABP: Intra-Aortic Balloon Pump (IABP) Study Notes

• Definition:
  The IABP is a hemodynamic augmentation device that assists the heart’s pumping ability by inflating and deflating a balloon in the aorta in sync with the cardiac cycle.

• Purpose:
  To improve cardiac output and coronary perfusion while reducing left ventricular workload (afterload).

2. Insertion and Positioning

• Primary access site: Femoral artery (most common).

• Alternative sites: Subclavian or axillary artery (if femoral route not possible).

• Catheter size: 8 Fr sheath.

• Final position:

  • The tip of the balloon should be 1 cm distal to the left subclavian artery in the descending thoracic aorta.

  • Placement confirmed by daily chest X-ray.

3. Mechanism of Action

Cardiac Phase	Balloon Action	Physiologic Effect
Diastole (after aortic valve closes)	Inflation	↑ Aortic diastolic pressure → ↑ Coronary perfusion
Systole (just before aortic valve opens)	Deflation	↓ Afterload → ↓ LV workload → ↑ Forward flow

4. Arterial Waveform Interpretation

Normal Arterial Waveform

• Systolic upstroke: LV contraction and blood ejection.

• Dicrotic notch: Aortic valve closure.

• Diastolic runoff: Gradual pressure decline during diastole.

IABP-Augmented Waveform

• Diastolic augmentation: Seen as a second, higher diastolic peak after the dicrotic notch.

• Represents the balloon inflation and rise in aortic diastolic pressure.

• Deflation before systole creates a small dip (vacuum effect) → reduced afterload.

5. Hemodynamic Effects

1. ↑ Diastolic Pressure (~30%) → improves coronary perfusion (since coronaries fill in diastole).

2. ↓ Afterload (~20%) → reduces LV wall stress and myocardial oxygen demand.

3. ↑ Cardiac Output via improved stroke volume efficiency.

4. ↓ LVEDP and PAWP (reflecting ventricular unloading).

Effectiveness decreases with severely impaired LV function—some contractile ability is needed for augmentation to be beneficial.

6. Clinical Indications

Indication	Rationale
Refractory myocardial ischemia	Increases coronary perfusion and reduces ischemic burden.
Cardiogenic shock	Temporarily supports circulation in acute LV failure (though IABP-SHOCK II trial showed no mortality benefit).
High-risk PCI	Provides peri-procedural support in patients with low EF or multivessel disease (BCIS-1 trial showed long-term benefit).
Refractory ventricular arrhythmias	Stabilizes perfusion during episodes of poor LV contraction.
Severe, decompensated heart failure	Used as a bridge therapy until more definitive intervention (e.g., LVAD, transplant).

7. Contraindications

Absolute (Hard):

• Severe aortic regurgitation (AR)

• Aortic dissection

• Severe peripheral arterial disease

• Coagulopathy

• Sepsis

Rationale:
Inflation in the presence of AR worsens regurgitation; dissection or vascular disease increases risk of rupture or ischemia.

8. Routine Care

• Daily chest X-ray → confirm proper position (1 cm below L subclavian).

• Continuous anticoagulation with heparin to prevent thrombosis.

• Frequent pulse checks → monitor for limb ischemia.

• Monitor labs (platelets, hemolysis markers).

• Strict sterile technique at insertion site.

9. Complications

Vascular Complications

• Limb ischemia (6–25% incidence)

• Arterial laceration or perforation

• Spinal cord or mesenteric ischemia

Thromboembolic/Embolic

• Cholesterol emboli → presents with livedo reticularis, thrombocytopenia, eosinophilia

  • Stop anticoagulation if suspected.

• Cerebrovascular accident (stroke) from embolic events.

Infectious

• Sepsis, especially if device in place >7 days.

• Groin site infection.

Hematologic

• Hemolysis

• Thrombocytopenia

10. Summary Table

Effect	Mechanism	Result
↑ Diastolic Pressure	Balloon inflation	↑ Coronary perfusion
↓ Afterload	Balloon deflation	↓ LV workload
↑ Stroke Volume	Reduced resistance	↑ Cardiac output
↓ LVEDP	Ventricular unloading	Improved filling dynamics

11. Key Studies

• IABP-SHOCK II Trial: No short- or long-term mortality benefit in cardiogenic shock.

• BCIS-1 Trial: Benefit in high-risk PCI patients (reduced late mortality).

12. Quick Review Mnemonic: “IABP = Inflate After, Before Pump”

• Inflate After aortic valve closes (diastole).

• Before Pump (deflate before LV contraction).

Summary:
The Intra-Aortic Balloon Pump (IABP) improves coronary perfusion and decreases left ventricular workload through timed balloon inflation and deflation in the aorta. While it offers short-term stabilization in cardiogenic shock and high-risk cardiac procedures, evidence for mortality benefit is mixed. Proper insertion, vigilant monitoring, and awareness of complications are essential for safe use.

Right Heart Catheterization (RHC) and Cardiovascular Pressure Measurement

Learning Objective

After reviewing this material, you should be able to:

• Explain how to determine important cardiovascular pressure values using the right heart catheterization technique (e.g., Swan-Ganz catheter).

• Understand the relationships between atrial, ventricular, and arterial pressures and how they are used to estimate cardiac function.

1. Overview of the Right Heart Catheterization Procedure

Catheter Used

• Balloon-tipped flow-directed catheter (e.g., Swan-Ganz catheter).

Pathway of Catheter Insertion

1. Insert through venous system (either internal jugular, subclavian, or femoral vein).

2. Pass through the following structures in order:

   • Right atrium (RA)

   • Across the tricuspid valve

   • Right ventricle (RV)

   • Across the pulmonic valve

   • Pulmonary artery (PA)

   • Finally, wedge into a small branch of the pulmonary artery

Purpose

• Measure pressures in each right heart chamber and estimate left-sided pressures.

• Especially useful for hemodynamic assessment in critically ill patients.

2. Pressure Measurement Sites and Values

Location	Waveform / Pressure Type	Normal Mean Pressure (mmHg)	Physiologic Significance
Right Atrium (RA)	a, c, v waves	2–8	Reflects venous return and right heart preload
Right Ventricle (RV)	Systolic/Diastolic waveform	15–25 / 0–8	Reflects RV contractility and diastolic filling
Pulmonary Artery (PA)	Systolic, Diastolic, Dicrotic notch	15–25 / 8–15	Indicates pulmonary vascular resistance
Pulmonary Capillary Wedge Pressure (PCWP)	a and v waves (similar to LA waveform)	6–12	Estimates Left Atrial Pressure (LAP) and LV End-Diastolic Pressure (LVEDP)

3. Understanding the Pressure Waveforms

Right Atrial (RA) Pressure Waveform

• a wave: Atrial contraction (after P-wave on ECG).

• c wave: Bulging of tricuspid valve during early ventricular systole.

• v wave: Passive venous filling during late systole.

• y descent: Atrial emptying when tricuspid valve opens.

Often, a and c waves merge, producing two main visible peaks: a and v.

Right Ventricle (RV) Pressure

• Rapid rise in systole → up to ~25 mmHg (ventricular contraction).

• Rapid fall in diastole → close to 0 mmHg.

• Reflects dynamic pumping function of the RV.

Pulmonary Artery (PA) Pressure

• Systolic pressure similar to RV systolic pressure (since pulmonic valve is open).

• Dicrotic notch = closure of pulmonic valve.

• Diastolic pressure higher than RV diastolic pressure due to resistance in pulmonary vasculature.

Pulmonary Capillary Wedge Pressure (PCWP)

• Obtained when catheter wedges into a small PA branch, occluding forward flow.

• The pressure transmitted back through the column of blood reflects left atrial pressure (LAP).

• Waveforms:

  • a wave: Left atrial contraction

  • v wave: Left atrial filling during systole

PCWP ≈ Mean Left Atrial Pressure (LAP) → useful for estimating LV End-Diastolic Pressure (LVEDP).

4. Pressure Relationships and Clinical Correlations

Parameter	Relationship / Estimation
Mean Right Atrial Pressure (RAP)	≈ RV End-Diastolic Pressure (RVEDP) (since tricuspid valve open during diastole)
Mean Pulmonary Capillary Wedge Pressure (PCWP)	≈ Left Ventricular End-Diastolic Pressure (LVEDP)
LVEDP	Pressure in LV just before mitral valve closes → corresponds to mitral component of S1
RVEDP	Pressure in RV just before tricuspid valve closes → corresponds to tricuspid component of S1

. Physical Examination Correlates

Jugular Venous Pressure (JVP)

• Observed as pulsations in the neck.

• Reflects central venous pressure (CVP) → approximate measure of right atrial pressure.

• Useful for assessing volume status and right heart function.

Arterial Blood Pressure (BP)

• Measured with sphygmomanometer.

• Reflects aortic pressure:

  • Systolic BP: Peak aortic pressure (during LV contraction).

  • Diastolic BP: Minimum aortic pressure (during LV relaxation).

6. Key Concepts

1. Catheter progression sequence:
   RA → RV → PA → PCWP

2. Valve relationships:

   • Tricuspid valve separates RA and RV

   • Pulmonic valve separates RV and PA

3. Waveform summary:

   • RA: a, c, v waves

   • RV: large systolic peak, near-zero diastolic trough

   • PA: dicrotic notch (valve closure)

   • PCWP: a and v waves similar to LA waveform

4. Clinical Utility:

   • Evaluate cardiac preload and afterload.

   • Diagnose pulmonary hypertension, cardiogenic shock, heart failure, etc.

7. Quick Reference Table

Chamber / Site	Systolic (mmHg)	Diastolic (mmHg)	Mean (mmHg)	Purpose
Right Atrium	—	—	2–8	Central venous pressure
Right Ventricle	15–25	0–8	—	RV contractility
Pulmonary Artery	15–25	8–15	10–20	Pulmonary resistance
PCWP	—	—	6–12	Estimate LAP/LVEDP

8. Summary

• Right heart catheterization (Swan-Ganz) allows direct measurement of right-sided pressures and indirect estimation of left heart filling pressures.

• PCWP serves as a reliable indicator of left atrial and left ventricular end-diastolic pressures.

• Pressure tracings and waveform recognition are key to interpreting hemodynamic status.

• JVP and arterial BP provide bedside correlates of central venous and systemic arterial pressures.